CDKL5 deficiency disorder therapeutic program (Vyant Bio Inc/Cyclica Inc)

N/A

Report date: 2025/01/26 16:26:51
NME

Base Information

Drug NameCDKL5 deficiency disorder therapeutic program (Vyant Bio Inc/Cyclica Inc)
Drug Alias NameVYNT-XXXX
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclin-dependent kinase-like 5 modulators
TargetsCyclin-dependent kinase-like 5
Therapy Area/IndicationsCentral Nervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVyant Bio Inc
China Registration ClassN/A

Develop Information

Active CompaniesCyclica IncVyant Bio Inc
Inactive CompaniesN/A
Active IndicationsCentral Nervous System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A